Herbalife LTD (Call) (HLF) Share Value Rose While Indus Capital Partners LLC Has Trimmed by $29.03 Million Its Holding

August 24, 2017 - By Marry Poplack

Investors sentiment decreased to 0.82 in 2016 Q4. Its down 0.13, from 0.95 in 2016Q3. It is negative, as 50 investors sold HLF shares while 67 reduced holdings. 34 funds opened positions while 62 raised stakes. 96.66 million shares or 9.73% more from 88.09 million shares in 2016Q3 were reported. Morgan Stanley, New York-based fund reported 1.09 million shares. Dreman Value Mngmt L L C accumulated 83 shares. Gsa Prtn Llp stated it has 0.11% of its portfolio in Herbalife Ltd. (NYSE:HLF). Nine Masts Cap Limited has 0.54% invested in Herbalife Ltd. (NYSE:HLF) for 44,830 shares. Nomura Inc accumulated 0% or 7,345 shares. First Quadrant Ltd Partnership Ca reported 0.14% of its portfolio in Herbalife Ltd. (NYSE:HLF). Us National Bank De stated it has 1,589 shares or 0% of all its holdings. Henderson Gru Public Limited Com stated it has 0% of its portfolio in Herbalife Ltd. (NYSE:HLF). Lyon Street Cap Ltd holds 98,679 shares or 2.43% of its portfolio. Blackrock Advisors Ltd Llc invested in 0% or 43,115 shares. Thompson Davis & owns 402 shares. Bnp Paribas Arbitrage holds 0% or 7,307 shares in its portfolio. Products Ptnrs Limited Liability Company reported 158,335 shares. State Street stated it has 1.09 million shares or 0% of all its holdings. Minnesota-based Waterstone Mgmt Limited Partnership has invested 2.13% in Herbalife Ltd. (NYSE:HLF).

David Kowitz decreased its stake in Herbalife Ltd (Call) (HLF) by 17.94% based on its latest 2016Q4 regulatory filing with the SEC. Indus Capital Partners Llc sold 604,800 shares as the company’s stock rose 17.28% with the market. The hedge fund run by David Kowitz held 2.77 million shares of the other pharmaceuticals company at the end of 2016Q4, valued at $133.17 million, down from 3.37M at the end of the previous reported quarter. Indus Capital Partners Llc who had been investing in Herbalife Ltd (Call) for a number of months, seems to be less bullish one the $6.49B market cap company. The stock rose 0.09% or $0.06 reaching $69.03. About 252,356 shares traded. Herbalife Ltd. (NYSE:HLF) has risen 20.65% since August 24, 2016 and is uptrending. It has outperformed by 3.95% the S&P500.

Indus Capital Partners Llc, which manages about $7.51B and $771.27M US Long portfolio, upped its stake in Baozun Inc by 1.07 million shares to 1.28 million shares, valued at $15.47M in 2016Q4, according to the filing.

More notable recent Herbalife Ltd. (NYSE:HLF) news were published by: Seekingalpha.com which released: “China Pledges To Eradicate Multi-Level Marketing” on August 17, 2017, also Seekingalpha.com with their article: “Herbalife: Pivoting To Legitimacy And Decline” published on August 03, 2017, Bloomberg.com published: “Herbalife Slides After Outlook Renews Fears About FTC Accord” on August 01, 2017. More interesting news about Herbalife Ltd. (NYSE:HLF) were released by: Reuters.com and their article: “Shares in Herbalife, Nu Skin tumble as China cracks down on pyramid schemes” published on August 14, 2017 as well as Investorplace.com‘s news article titled: “Why Herbalife Ltd. (HLF), JD.Com Inc(ADR) (JD) and Tenet Healthcare Corp (THC …” with publication date: August 14, 2017.

Herbalife Ltd. (NYSE:HLF) Ratings Coverage

Among 7 analysts covering Herbalife (NYSE:HLF), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 43% are positive. Herbalife had 20 analyst reports since August 6, 2015 according to SRatingsIntel. Pivotal Research maintained the stock with “Buy” rating in Tuesday, August 4 report. The firm earned “Buy” rating on Wednesday, November 4 by Pivotal Research. Tigress Financial maintained the shares of HLF in report on Thursday, August 3 with “Buy” rating. As per Monday, June 5, the company rating was maintained by Pivotal Research. The company was upgraded on Friday, August 7 by Zacks. The firm earned “Buy” rating on Friday, May 5 by Pivotal Research. The stock of Herbalife Ltd. (NYSE:HLF) has “Buy” rating given on Wednesday, July 19 by Pivotal Research. On Monday, August 31 the stock rating was downgraded by Vetr to “Buy”. The firm has “Buy” rating by Vetr given on Friday, August 7. Pivotal Research maintained it with “Buy” rating and $12000 target in Wednesday, August 2 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.